Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Insulet Presents Omnipod for Medicaid Coverage Expansion
Trusted by teams at
Description
The Evidence-based Guidelines Subcommittee received vendor testimony from Insulet Corporation about Omnipod, a tubeless insulin pump, as part of their review to expand Medicaid coverage. No vote on contract or procurement was held but considerations included clinical efficacy and market access.
Contract Details
Vendor
INSULET CORPORATION
Agency
Oregon HA | Health Evidence Review Commission, OR
Contract Type
EQUIPMENT
Document Date
March 15, 2026
More from INSULET CORPORATION
Related Contracts
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
DISCUSSSEDOregon Health Authority Health Evidence Review Commission Written Public Comments Feb 2026
DISCUSSSEDOregon Health Authority Health Evidence Review Commission Written Public Comments Feb 2026
DISCUSSEDMore from Oregon HA | Health Evidence Review Commission
Oregon HA Health Evidence Review Commission Report Acellular Scaffold Implant March 2026
Oregon Health Authority Public Comments March 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.